SEARCH

SEARCH BY CITATION

References

  • 1
    Bernatsky S, Joseph L, Pineau CA, Tamblyn R, Feldman DE, Clarke AE. A population-based assessment of systemic lupus erythematosus incidence and prevalence--results and implications of using administrative data for epidemiological studies. Rheumatology (Oxford) 2007;46:18148.
  • 2
    Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 2005;32:170912.
  • 3
    Ruiz-Irastorza G, Lima F, Alves J, Khamashta MA, Simpson J, Hughes GR et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 1996;35:1338.
  • 4
    Day CJ, Lipkin GW, Savage CO. Lupus nephritis and pregnancy in the 21st century. Nephrol Dial Transplant 2009;24:3447.
  • 5
    Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: ten questions and some answers. Lupus 2008;17:41620.
  • 6
    Clowse MEB, Jamison M, Myesr E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008;199:127.e16.
  • 7
    Izmirly PM, Rivera TL, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin N Am 2007;33:26785.
  • 8
    Ruiz-Irastorza G, Khamashta MA. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 2009;23:57582.
  • 9
    Andrade RM, Mcgwin G, Alarcon GS, Sanchez ML, Bertoli AM, Fernández M et al. Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII). Rheumatology 2006;45:13804.
  • 10
    Chakravarty EF, Colón I, Langen ES, Nix DA, El-Sayed YY, Genovese MC et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 2005;192:1897904.
  • 11
    Andrade R, Sanchez ML, Alarcón GS, Fessler BJ, Fernández M, Bertoli AM et al. Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI). Clin Exp Rheumatol 2008;26:26874.
  • 12
    Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991;34:153845.
  • 13
    Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J. Lupus and pregnancy studies. Arthritis Rheum 1993;36:13927.
  • 14
    Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, Seebacher J, Lefébvre G, Blétry O et al. Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol 1997;36:7727.
  • 15
    Petri M. The Hopkins Lupus Pregnancy Center: ten key issues in management. Rheum Dis Clin North Am 2007;33:22735.
  • 16
    Levy RA, Vilela VS, Cataldo MJ, Ramos RC, Duarte JL, Tura BR et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 2001;10:4014.
  • 17
    Clowse M, Magder L, Witter F, Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 2006;54:36407.
  • 18
    Clowse MEB, Magder LS, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005;52:51421.
  • 19
    Buyon JP, Kalunian KC, Ramsey-Goldman R, Petri MA, Lockshin MD, Ruiz-Irastorza G et al. Assessing disease activity in SLE patients during pregnancy. Lupus 1999;8:67784.
  • 20
    Ruiz-Irastorza G, Khamashta MA, Gordon C, Lockshin MD, Johns KR, Sammaritano L et al. Measuring systemic lupus erythematosus activity during pregnancy: validation of the Lupus Activity Index in Pregnancy scale. Arthritis Rheum 2004;51:7882.
  • 21
    Mackillop LH, Germain SJ, Nelson-Piercy C. Systemic lupus erythematosus. Br Med J 2007;335:9336.
  • 22
    Østensen M, Khamashta MA, Lockshin M, Parke A, Brucato A, Carp H et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8:20927.
  • 23
    Gladman DD, Tandon A, Ibañez D, Urowitz M. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol 2010;37:7548.
  • 24
    Rahman FZ, Rahman J, Al-Suleiman SA, Rahman MS. Pregnancy outcome in lupus nephropathy. Arch Gynecol Obstet 2005;271:2226.
  • 25
    Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dialysis Transplant 2009;24:51925.
  • 26
    Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus 2006;15:14855.
  • 27
    Smyth A, Oliveira G, Lahr B, Bailey K, Norby S, Garovic V. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5:20608.
  • 28
    Milne F, Redman C, Walker J, Baker P, Bradley J, Cooper C et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. Br Med J 2005;330:57680.
  • 29
    Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, on behalf of the PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007;369:17918.
  • 30
    Nodler J, Moolamalla SR, Ledger EM, Nuwayhid BS, Mulla ZD. Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset. BMC Pregnancy Childbirth 2009;9:11.
  • 31
    Yamada H, Atsumi T, Kobashi G, Ota C, Kato E, Tsuruga N et al. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J Reprod Immunol 2009;79:18895.
  • 32
    Ruffatti A, Calligaro A, Hoxha A, Trevisanuto D, Ruffatti AT, Gervasi MT et al. Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome. Arthritis Care Res 2010;62:3027.
  • 33
    Bramham K, Hunt BJ, Germain S, Calatayud I, Khamashta MA, Bewley S et al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus 2010;9:5864.
  • 34
    Ruiz-Irastorza G, Crowther MA, Branch DW, Khamashta MA. Antiphospholipid syndrome. Lancet 2010;376:1498509.
  • 35
    Carmona F, Font J, Cervera R, Muñoz F, Cararach V, Balasch J. Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol 1999;83:13742.
  • 36
    Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:844S886.
  • 37
    Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green Top Guideline nº 37; November 2009.
  • 38
    Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:18325.
  • 39
    Friedman D, Llanos C, Izmirly PM, Brock B, Byron J, Copel J et al. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum 2010;62:113846.
  • 40
    Pisoni C, Brucato A, Ruffatti A, Espinosa G, Cervera R, Belmonte-Serrano M et al. Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study. Arthritis Rheum 2010;62:114752.
  • 41
    Izmirly PM, Kim MY, Llanos C, Le PU, Guerra MM, Askanase AD et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis 2010;69:182730.
  • 42
    Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010;69:208.
  • 43
    Sperber K, Hom C, Chao CP, Shapiro D, Ash J. Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr Rheumatol Online J 2009;7:9.doi: 10.1186/1546-0096-7-9.
  • 44
    Vinet E, Pineau C, Gordon C, Clarke A, Bernatsky SR. Biologic therapy and pregnancy outcomes in women with rheumatic diseases. Arthritis Rheum 2009;61:58792.
  • 45
    Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:244351.
  • 46
    Nelson- Piercy C. Handbook of Obstetric Medicine, 3rd edn. London: Informa Healthcare, 2006.
  • 47
    Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoat N, Andreu MR et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 2006;45:3328.
  • 48
    Castellino G, Capucci R, Govoni M, Mollica G, Trotta F. Uterine artery Doppler in predicting pregnancy outcome in women with connective tissue disorders. Rheumatology (Oxford) 2006;45:11745.